China Medical System (CMS) (00867) said it noticed that Shanghai-listed Tibet Rhodiola Pharmaceutical Holdings Co., Ltd. issued an announcement that certain shareholders of the Tibet Pharmaceutical, including Shenzhen Kangzhe Pharmaceutical, a wholly-owned subsidiary of CMS, are considering entering into discussions in relation to certain matters concerning Tibet Pharmaceutical.
It further mentions that the outcome of such discussion is uncertain and may involve significant matters.
Shenzhen Kangzhe Pharmaceutical, together with other members of the CMS Group, hold an aggregate of about 8.64% stake in Tibet Pharmaceutical.
全新節目《說說心理話》原生家庭對成長有咩影響?改善溝通有計可施?► 即睇